Skip to main content
. Author manuscript; available in PMC: 2016 Jun 24.
Published in final edited form as: Stat Biopharm Res. 2015 Jun 24;7(2):126–147. doi: 10.1080/19466315.2015.1004270

Table 2.

Descriptors for the patterns of evidence we consider for both the global and closure cases.

Proportion of Alternatives(π)

Power



(βBon)

0.50

0.75

0.90
0.10 0.50 0.90
Moderate & Sparse Moderate & Even Moderate & Concentrated
Strong & Sparse Strong and Even Strong and Concentrated
Very Strong & Sparse Very Strong & Even Very Strong & Concentrated